SLNObenzinga

Soleno Therapeutics Says FDA Approved VYKAT XR Extended-Release Tablets For Treatment Of Hyperphagia In Adults And Children 4 Years Of Age And Older With Prader-Willi Syndrome

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 26, 2025 by benzinga